BRIAN A MARKISON
CIK 1283061 · CEO · last filed 2025-03-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$26.64M
Companies
9
Total Filings
90
Lifetime Open-Market Net
-$6.19M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNTH | CEO | 232,420 | $104.52 | $24.29M | -$6.52M | 32 | 2025-03-07 |
| RVL Pharmaceuticals plc (RVLP) Delisted | Chief Executive Officer | 2,976,020 | $0.03 | $83.9K | $1.32M | 1 | 2022-08-09 |
| RVL Pharmaceuticals plc (OSMT) Delisted | Chief Executive Officer | 2,126,020 | $1.11 | $2.36M | $0 | 3 | 2021-11-08 |
| Organogenesis Holdings Inc. (AHPAW) Delisted | Director | — | $0.69 | — | $0 | 5 | 2018-12-12 |
| IMMUNOMEDICS INC (IMMU) Delisted | Director | 90,788 | — | — | -$167.8K | 16 | 2017-11-21 |
| ALERE INC. (ALRpB) Delisted | Director | 0 | — | — | $0 | 4 | 2017-10-03 |
| Organogenesis Holdings Inc. (AHPAU) Delisted | Director | — | $6.16 | — | $0 | 1 | 2016-11-29 |
| Altimmune, Inc. (PIP) Delisted | Director | — | — | — | $0 | 4 | 2015-01-05 |
| KG | President and CEO | 200,760 | $11.68 | $2.34M | -$817.7K | 24 | 2011-02-02 |
Recent Filings · Page 2 of 9
90 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-10 | LNTH | Grant (A) | +2,180 | $0 | EDGAR |
| 2021-11-08 | RVL Pharmaceuticals plc (OSMT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-12 | LNTH | Grant (A) | +8,513 | $0 | EDGAR |
| 2020-10-05 | LNTH | Grant (A) | +2,277 | $0 | EDGAR |
| 2020-08-12 | LNTH | Grant (A) | +1,354 | $0 | EDGAR |
| 2020-05-22 | RVL Pharmaceuticals plc (OSMT) Delisted | Grant (A) | +249,787 | $0 | EDGAR |
| 2020-03-05 | LNTH | Grant (A) | +8,095 | $0 | EDGAR |
| 2019-07-12 | LNTH | Sell (S) | −4,918 | -$138.0K | EDGAR |
| 2019-07-05 | LNTH | Sell (S) | −5,000 | -$142.1K | EDGAR |
| 2019-06-28 | LNTH | Sell (S) | −5,000 | -$138.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.